{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:07:14Z","timestamp":1760267234396,"version":"build-2065373602"},"reference-count":122,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.jaut.2013.06.014","type":"journal-article","created":{"date-parts":[[2013,7,13]],"date-time":"2013-07-13T16:01:07Z","timestamp":1373731267000},"page":"88-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Clinical management of autoimmune biliary diseases"],"prefix":"10.1016","volume":"46","author":[{"given":"Mohamad H.","family":"Imam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayant A.","family":"Talwalkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith D.","family":"Lindor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2013.06.014_bib1","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2013.06.014_bib2","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1053\/gast.2000.20197","article-title":"Epidemiology and natural history of primary biliary cirrhosis in a US community","volume":"119","author":"Kim","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2013.06.014_bib3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4321\/S1130-01082009000600007","article-title":"The pathogenesis of primary biliary cirrhosis","volume":"101","author":"Solis Herruzo","year":"2009","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.jaut.2013.06.014_bib4","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/hep.23139","article-title":"Are transient environmental agents involved in the cause of primary biliary cirrhosis? Evidence from space-time clustering analysis","volume":"50","author":"McNally","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.06.014_bib5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.it.2009.05.006","article-title":"The role of environmental factors in primary biliary cirrhosis","volume":"30","author":"Selmi","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaut.2013.06.014_bib6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.789","article-title":"Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis","volume":"43","author":"Mells","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaut.2013.06.014_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1399-0039.2010.01600.x","article-title":"Genetic association of Fc receptor-like 3 polymorphisms with susceptibility to primary biliary cirrhosis: ethnic comparative study in Japanese and Italian patients","volume":"77","author":"Tanaka","year":"2011","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jaut.2013.06.014_bib8","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ajhg.2012.08.010","article-title":"Genome-wide Association Study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population","volume":"91","author":"Nakamura","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaut.2013.06.014_bib9","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.06.014_bib10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/hep.510300101","article-title":"Primary sclerosing cholangitis","volume":"30","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.06.014_bib11","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/hep.23678","article-title":"Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden","volume":"52","author":"Lindkvist","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.06.014_bib12","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.gastro.2003.07.011","article-title":"Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community","volume":"125","author":"Bambha","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2013.06.014_bib13","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1572-0241.2007.01103.x","article-title":"The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis","volume":"102","author":"Kaplan","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaut.2013.06.014_bib14","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/hep.24247","article-title":"Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"53","author":"Molodecky","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.06.014_bib15","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/0016-5085(91)70028-V","article-title":"Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis","volume":"100","author":"Duerr","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2013.06.014_bib16","first-page":"30","article-title":"Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis","volume":"76","author":"Snook","year":"1989","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2013.06.014_bib17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0016-5085(85)80141-4","article-title":"Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis","volume":"88","author":"Wiesner","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2013.06.014_bib18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.clinre.2012.07.008","article-title":"Antineutrophil cytoplasmic auto-antibodies (ANCA) in autoimmune hepatitis and primary sclerosing cholangitis","volume":"37","author":"Deniziaut","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jaut.2013.06.014_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/00365528209182038","article-title":"HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease","volume":"17","author":"Schrumpf","year":"1982","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jaut.2013.06.014_bib20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/hep.1840130119","article-title":"Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis","volume":"13","author":"Donaldson","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.06.014_bib21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/gut.24.1.38","article-title":"Association of primary sclerosing cholangitis with HLA-B8","volume":"24","author":"Chapman","year":"1983","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2013.06.014_bib22","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/gut.33.7.942","article-title":"HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease: no HLA-DRw52a association in Swedish patients with sclerosing cholangitis","volume":"33","author":"Zetterquist","year":"1992","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2013.06.014_bib23","article-title":"Genome-wide association analysis in sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4","author":"Ellinghaus","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.06.014_bib24","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3109\/00365521.2012.682090","article-title":"Fine mapping and replication of genetic risk loci in primary sclerosing cholangitis","volume":"47","author":"Srivastava","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jaut.2013.06.014_bib25","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jhep.2012.03.031","article-title":"Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci","volume":"57","author":"Folseraas","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2013.06.014_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0002-9610(66)90339-4","article-title":"Primary sclerosing cholangitis. A\u00a0study of forty-two cases","volume":"111","author":"Warren","year":"1966","journal-title":"Am J Surg"},{"key":"10.1016\/j.jaut.2013.06.014_bib27","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00004836-198410000-00006","article-title":"Hepatobiliary disease that precedes ulcerative colitis","volume":"6","author":"Steckman","year":"1984","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jaut.2013.06.014_bib28","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/hep.1840010612","article-title":"Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis","volume":"1","author":"Ludwig","year":"1981","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.06.014_bib29","first-page":"235","article-title":"The diagnostic importance of ACTH","volume":"5","author":"Waldenstrom","year":"1950","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.jaut.2013.06.014_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0002-9343(56)90003-1","article-title":"The problem of chronic liver disease in young women","volume":"21","author":"Bearn","year":"1956","journal-title":"Am J Med"},{"key":"10.1016\/j.jaut.2013.06.014_bib31","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","article-title":"Meeting report: International Autoimmune Hepatitis Group","volume":"18","author":"Johnson","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.06.014_bib32","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/0016-5085(93)90359-K","article-title":"Early-onset autoimmune hepatitis is associated with a C4A gene deletion","volume":"104","author":"Scully","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2013.06.014_bib33","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/hep.1840180411","article-title":"Genetic predispositions for the immunological features of chronic active hepatitis","volume":"18","author":"Czaja","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.06.014_bib34","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1499-3872(12)60136-2","article-title":"Association of polymorphisms in non-classic MHC genes with susceptibility to autoimmune hepatitis","volume":"11","author":"Tang","year":"2012","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.jaut.2013.06.014_bib35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1478-3231.2011.02502.x","article-title":"Prognostic implications of\u00a0antibodies to Ro\/SSA and soluble liver antigen in type 1 autoimmune hepatitis","volume":"32","author":"Montano-Loza","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.jaut.2013.06.014_bib36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1155\/2012\/890698","article-title":"Clinical significance of autoantibodies to p53 protein in patients with autoimmune liver diseases","volume":"26","author":"Himoto","year":"2012","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.jaut.2013.06.014_bib37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/hep.20287","article-title":"Cost-minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitis","volume":"40","author":"Talwalkar","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.06.014_bib38","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5507\/bp.2011.044","article-title":"Endosonography versus endoscopic retrograde cholangiopancreatography in diagnosing extrahepatic biliary obstruction","volume":"155","author":"Tozzi di Angelo","year":"2011","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"10.1016\/j.jaut.2013.06.014_bib39","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0140-6736(87)91610-2","article-title":"Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?","volume":"1","author":"Poupon","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2013.06.014_bib40","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/all.12019","article-title":"Ursodeoxycholic acid suppresses eosinophilic airway inflammation by inhibiting the function of dendritic cells through the nuclear farnesoid X receptor","volume":"67","author":"Willart","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaut.2013.06.014_bib41","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM199105303242204","article-title":"A\u00a0multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group","volume":"324","author":"Poupon","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2013.06.014_bib42","first-page":"759","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis","volume":"22","author":"Combes","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.06.014_bib43","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/hep.1840190512","article-title":"The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis","volume":"19","author":"Heathcote","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.06.014_bib44","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1572-0241.2004.04047.x","article-title":"Prolonged follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis","volume":"99","author":"Combes","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaut.2013.06.014_bib45","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/hep.510290444","article-title":"Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression","volume":"29","author":"Degott","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.06.014_bib46","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0168-8278(03)00192-2","article-title":"Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis","volume":"39","author":"Poupon","year":"2003","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2013.06.014_bib47","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1053\/gast.1996.v110.pm8613058","article-title":"Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis","volume":"110","author":"Lindor","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2013.06.014_bib48","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM199405123301903","article-title":"Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group","volume":"330","author":"Poupon","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2013.06.014_bib49","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4065\/72.12.1137","article-title":"Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis","volume":"72","author":"Lindor","year":"1997","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaut.2013.06.014_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000551.pub2","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis","author":"Gong","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaut.2013.06.014_bib51","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/j.1572-0241.2006.00634.x","article-title":"Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials","volume":"101","author":"Shi","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaut.2013.06.014_bib52","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","article-title":"Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid","volume":"130","author":"Pares","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2013.06.014_bib53","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22428","article-title":"Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis","volume":"48","author":"Corpechot","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.06.014_bib54","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.jhep.2011.02.031","article-title":"Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome","volume":"55","author":"Corpechot","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2013.06.014_bib55","doi-asserted-by":"crossref","unstructured":"Honda A, Ikegami T, Nakamuta M, Miyazaki T, Iwamoto J, Hirayama T, et al., Anticholestatic effects of bezafibrate in patients with primary biliary cirrhosis treated with ursodeoxycholic acid, 57, Hepatology, 1931\u20131941.","DOI":"10.1002\/hep.26018"},{"key":"10.1016\/j.jaut.2013.06.014_bib56","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.cgh.2011.05.010","article-title":"Colchicine or methotrexate, with ursodiol, are effective after 20 years in a subset of patients with primary biliary cirrhosis","volume":"9","author":"Leung","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaut.2013.06.014_bib57","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/hep.24748","article-title":"Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid","volume":"55","author":"Tsuda","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.06.014_bib58","first-page":"416A","article-title":"The first new monotherapy therapeutic PBC study in a decade? An international study evaluating the farnesoid X receptor agonist obeticholic acid in PBC","volume":"54","author":"Kowdley","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.06.014_bib59","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.trsl.2009.09.009","article-title":"Treatment of primary biliary cirrhosis with tetrathiomolybdate: results of a double-blind trial","volume":"155","author":"Askari","year":"2010","journal-title":"Transl Res"},{"key":"10.1016\/j.jaut.2013.06.014_bib60","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/hep.26067","article-title":"Therapeutic effect of CTLA4-Ig on a murine model of primary biliary cirrhosis","volume":"57","author":"Dhirapong","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.06.014_bib61","article-title":"Chlorambucil for patients with primary biliary cirrhosis","volume":"9","author":"Li","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaut.2013.06.014_bib62","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.cgh.2007.07.015","article-title":"Transplantation trends in primary biliary cirrhosis","volume":"5","author":"Lee","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaut.2013.06.014_bib63","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1056\/NEJM198906293202602","article-title":"Efficiency of liver transplantation in patients with primary biliary cirrhosis","volume":"320","author":"Markus","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2013.06.014_bib64","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/hep.510260508","article-title":"Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes","volume":"26","author":"Jones","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.06.014_bib65","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1053\/jhep.2002.33202","article-title":"Small-duct primary sclerosing cholangitis: a long-term follow-up study","volume":"35","author":"Angulo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.06.014_bib66","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00535-011-0465-z","article-title":"Diagnostic criteria for IgG4-related sclerosing cholangitis based on cholangiographic classification","volume":"47","author":"Nakazawa","year":"2012","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jaut.2013.06.014_bib67","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.06.014_bib68","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/j.1365-2036.2011.04863.x","article-title":"High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis","volume":"34","author":"Imam","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaut.2013.06.014_bib69","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/ajg.2011.156","article-title":"High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"106","author":"Eaton","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaut.2013.06.014_bib70","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1053\/j.gastro.2005.07.042","article-title":"Inflammatory bowel disease extending its reach","volume":"129","author":"Loftus","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2013.06.014_bib71","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis","volume":"38","author":"Broome","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2013.06.014_bib72","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC\u2013IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2013.06.014_bib73","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/gut.2010.235408","article-title":"Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?","volume":"60","author":"Marelli","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2013.06.014_bib74","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/0016-5085(92)90308-L","article-title":"Primary sclerosing cholangitis in ulcerative colitis\u2013a risk factor for the development of dysplasia and DNA aneuploidy?","volume":"102","author":"Broome","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2013.06.014_bib75","first-page":"1285","article-title":"The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis","volume":"92","author":"Marchesa","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaut.2013.06.014_bib76","first-page":"26","article-title":"Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis and the risk of developing malignancies. A large prospective study","volume":"38","author":"Terg","year":"2008","journal-title":"Acta Gastroenterol Latinoam"},{"key":"10.1016\/j.jaut.2013.06.014_bib77","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2006-933561","article-title":"Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer","volume":"26","author":"Broome","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jaut.2013.06.014_bib78","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1053\/j.gastro.2008.01.042","article-title":"The natural history of small-duct primary sclerosing cholangitis","volume":"134","author":"Bjornsson","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2013.06.014_bib79","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/gut.51.5.731","article-title":"Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis","volume":"51","author":"Bjornsson","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2013.06.014_bib80","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0168-8278(02)00036-3","article-title":"Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC)","volume":"36","author":"Broome","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2013.06.014_bib81","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ajg.2011.375","article-title":"The spectrum of sclerosing cholangitis and the relevance of IgG4 elevations in routine practice","volume":"107","author":"Alswat","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaut.2013.06.014_bib82","first-page":"536","article-title":"Clinical diagnostic criteria of IgG4-related sclerosing cholangitis","volume":"19","author":"Ohara","year":"2012","journal-title":"J Hepato"},{"key":"10.1016\/j.jaut.2013.06.014_bib83","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1572-0241.2006.00772.x","article-title":"Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis","volume":"101","author":"Mendes","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaut.2013.06.014_bib84","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","article-title":"Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy","volume":"134","author":"Ghazale","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2013.06.014_bib85","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.dld.2010.12.008","article-title":"Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis","volume":"43","author":"Stanich","year":"2011","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jaut.2013.06.014_bib86","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/jhep.2002.31872","article-title":"Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis","volume":"35","author":"Boberg","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.06.014_bib87","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/gut.51.4.562","article-title":"Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population","volume":"51","author":"Ponsioen","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2013.06.014_bib88","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1055\/s-0030-1255527","article-title":"Validation of a cholangiographic prognostic model in primary sclerosing cholangitis","volume":"42","author":"Ponsioen","year":"2010","journal-title":"Endoscopy"},{"key":"10.1016\/j.jaut.2013.06.014_bib89","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1016\/j.transproceed.2009.09.044","article-title":"Prediction of graft loss and death in patients with primary sclerosing cholangitis","volume":"41","author":"Kornasiewicz","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jaut.2013.06.014_bib90","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0025-6196(11)64614-4","article-title":"A\u00a0revised natural history model for primary sclerosing cholangitis","volume":"75","author":"Kim","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaut.2013.06.014_bib91","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1053\/jlts.2000.18485","article-title":"Predicting clinical and economic outcomes after liver transplantation using the Mayo primary sclerosing cholangitis model and Child-Pugh score. National Institutes of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database Group","volume":"6","author":"Talwalkar","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jaut.2013.06.014_bib92","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1053\/gast.1996.v110.pm8566577","article-title":"Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis","volume":"110","author":"Brentnall","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2013.06.014_bib93","first-page":"1404","article-title":"Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential","volume":"22","author":"Broome","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.06.014_bib94","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1111\/j.1572-0241.1999.01156.x","article-title":"The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis","volume":"94","author":"Shetty","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaut.2013.06.014_bib95","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/gut.41.4.522","article-title":"Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study","volume":"41","author":"Kornfeld","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2013.06.014_bib96","first-page":"1174","article-title":"Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis","volume":"88","author":"D'Haens","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaut.2013.06.014_bib97","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1067\/mge.2002.125367","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis\u00a0and ulcerative colitis: a meta-analysis","volume":"56","author":"Soetikno","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jaut.2013.06.014_bib98","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cgh.2011.10.020","article-title":"Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis","volume":"10","author":"Braden","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaut.2013.06.014_bib99","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"Bergquist","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2013.06.014_bib100","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/003655202760373434","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation","volume":"37","author":"Boberg","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jaut.2013.06.014_bib101","first-page":"1563","article-title":"A\u00a0comparative study of patients undergoing liver transplantation for primary sclerosing cholangitis and primary biliary cirrhosis","volume":"23","author":"McEntee","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jaut.2013.06.014_bib102","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hep.510300501","article-title":"Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis","volume":"30","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.06.014_bib103","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/0016-5085(92)91449-E","article-title":"Primary sclerosing cholangitis: refinement and validation of survival models","volume":"103","author":"Dickson","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2013.06.014_bib104","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2003.50016","article-title":"Model for end-stage liver disease (MELD) and allocation of donor livers","volume":"124","author":"Wiesner","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2013.06.014_bib105","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/lt.21313","article-title":"Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jaut.2013.06.014_bib106","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/lt.21679","article-title":"A\u00a0re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts","volume":"15","author":"Alabraba","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jaut.2013.06.014_bib107","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis","volume":"354","author":"Krawitt","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2013.06.014_bib108","first-page":"159","article-title":"Controlled prospective trial of corticosteroid therapy in active chronic hepatitis","volume":"40","author":"Cook","year":"1971","journal-title":"Q\u00a0J Med"},{"key":"10.1016\/j.jaut.2013.06.014_bib109","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/hep.510280210","article-title":"Frequency and nature of the variant syndromes of autoimmune liver disease","volume":"28","author":"Czaja","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.06.014_bib110","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/hep.21229","article-title":"Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis","volume":"44","author":"Poupon","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.06.014_bib111","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cgh.2011.03.019","article-title":"Prevalence of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome","volume":"9","author":"Bonder","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaut.2013.06.014_bib112","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/ajg.2009.126","article-title":"The serological profile of the autoimmune hepatitis\/primary biliary cirrhosis overlap syndrome","volume":"104","author":"Muratori","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaut.2013.06.014_bib113","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1572-0241.2007.01136.x","article-title":"Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes","volume":"102","author":"Silveira","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaut.2013.06.014_bib114","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0168-8278(00)80004-5","article-title":"Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system","volume":"33","author":"Kaya","year":"2000","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2013.06.014_bib115","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1034\/j.1600-0641.2000.033004543.x","article-title":"High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis","volume":"33","author":"van Buuren","year":"2000","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2013.06.014_bib116","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0168-8278(96)80266-2","article-title":"Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis","volume":"24","author":"Gohlke","year":"1996","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2013.06.014_bib117","first-page":"1415","article-title":"Primary sclerosing cholangitis in 32 children: clinical, laboratory, and radiographic features, with survival analysis","volume":"22","author":"Wilschanski","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.06.014_bib118","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.06.014_bib119","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/hep.23024","article-title":"Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: a prospective magnetic resonance imaging and histological study","volume":"50","author":"Lewin","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.06.014_bib120","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/hep.22073","article-title":"Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: evaluating the role of routine magnetic resonance imaging","volume":"47","author":"Abdalian","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.06.014_bib121","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1572-0241.1998.224_a.x","article-title":"Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases","volume":"93","author":"McNair","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaut.2013.06.014_bib122","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841113000887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841113000887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:09:25Z","timestamp":1760256565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841113000887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":122,"alternative-id":["S0896841113000887"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2013.06.014","relation":{},"ISSN":["0896-8411"],"issn-type":[{"type":"print","value":"0896-8411"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical management of autoimmune biliary diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2013.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}